Seeking Alpha

Vivus, Inc. (VVUS)

  • jonbaker22 | Send Message 21 Mar

    $VVUS close above the 50 DMA, Their ED drug Stendra will Blow others away Green light Strong buy here.
      • StockConsultant | Send Message 16 Mar

        $VVUS stock nice bounce off support, a big "Stocks to Watch" mover along with $EW $INO $KNDI $SIGM today
          • Clinically Sound Investor | Send Message 16 Mar

            Vivus' Qsymia Breaks 3-Week Stagnancy, Could Start Upward Trend $VVUS
              • Spencer Osborne | Send Message 13 Mar

                Vivus - Qsymia Scripts Pass 11,000 For First Time In 2015 $VVUS
                  • SA Editor Mike Taylor | Send Message 13 Mar

                    Biotech Weekly: Deeper Looks At $OREX, $PCYC, And $ACAD, plus news about $MRK $GSK $GILD $VVUS $ILMN $EXAC and more $ZGNX $JNJ $GERN $XBI
                      • pat45 | Send Message 11 Mar

                        $VVUS Big shareholders want at least $10-15 in buyout. Don't know if this can be done.
                          • Spencer Osborne | Send Message 11 Mar

                            Vivus - Teva Wants To Make Generic Qsymia - Can This Be Good? $VVUS
                              • Joe Springer | Send Message 9 Mar

                                Weight Loss, Cash, And Fuel Cells $OREX, $VVUS, $ARNA
                                  • Joe Springer | Send Message 9 Mar

                           Despite FDA Consternation, Contrave Looks Good US, Soon Win Europe Approval $OREX $ARNA $VVUS $NVO $ETRM $ZFGN
                                      • Spencer Osborne | Send Message 7 Mar

                                        Vivus' Suit Against Actavis Gets Some Dates - Is Trouble Ahead? $VVUS, $ACT
                                          Visit Seeking Alpha's
                                          VVUS vs. ETF Alternatives
                                          Company Description
                                          Vivus is a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States